Home > Clinical Research
EarlySign technology identifies ‘rising risk’ individuals of the population who are most likely to become tomorrow’s high burden patients. The goal is to flag these patients in time to enable healthcare providers to undertake preventative action. This 5% of the population ultimately accounts for 50% of healthcare costs.
Medial EarlySign is doing clinical data research to predict and flag prediabetic patients at high risk for becoming diabetic within a specified timeframe where early care could make a difference.
Our mission of surfacing hidden insights to improve healthcare is augmented by partnerships with leading global institutes. Our partners take part in the exciting transition to data-driven healthcare, and co-authors of our primary research, they enjoy close access to the research process, becoming key players in the development process.